Skip to main content

Table 4 Adverse events (AEs)

From: Analysis of clinical features, treatment response, and prognosis among 61 elderly newly diagnosed multiple myeloma patients: a single-center report

Adverse events (AEs) Bortezomib-containing regimens Thalidomide-containing regimens
Case (%) (n = 39) (n = 22)
Gastrointestinal symptoms 23 (60 %) 7 (31.8 %)
Infection (bacterial or/and fungal) 12 (30.8 %) 14 (63.6 %)
Peripheral neuropathy 12 (30.8 %) 6 (27.3 %)
Cytopenia 8 (20.5 %) 4 (18.2 %)
Hyperglycemia 5 (12.8 %) 5 (22.7 %)
Thrombosis 0 3 (13.6 %)
Herpes zoster 2 (5.1 %) 0
Arrhythmia 1 (2.6 %) 1 (4.6 %)
Rash 1 (2.6 %) 1 (4.6 %)